Abstract

[This corrects the article DOI: 10.18632/oncotarget.15577.].

Highlights

  • Ground-glass opacity (GGO) is defined as an area of hazy increased attenuation that does not obscure underlying bronchial structures or vascular markings on high-resolution computed tomography (HRCT) [1]

  • Significant differences were found in the diameter of GGN (DGGN), Dsolid, and consolidation/ tumor ratio (CTR) between the two groups

  • DGGN and Dsolid were respectively correlated with both SUVmax and CTR, whereas cystic appearance was reverse correlated with both SUVmax and CTR

Read more

Summary

Introduction

Ground-glass opacity (GGO) is defined as an area of hazy increased attenuation that does not obscure underlying bronchial structures or vascular markings on high-resolution computed tomography (HRCT) [1]. Patients with stage IA lung adenocarcinoma (i.e., peripheral lung cancers ≤ 3 cm in diameter without nodal and distant metastasis), usually present as a solitary ground-glass opacity nodule (GGN) on HRCT [2,3,4,5], and have a 5-year disease-free survival rate approaching 88% [6]. A percentage of 0.5 or less of the solid component of a GGN can identify early lung adenocarcinoma with clinical T1bN0M0 patients [13] and can be a useful independent preoperative prognostic indicator [23]. Among various strategies over morphologic evaluation, contrast-enhanced and dynamic MDCT have been applied to assess malignant GGNs with limited additional information [12]. Perfusion MDCT shows us promising for lung cancer [24], the increased radiation dose restricts its clinical application

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call